Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MiRNA Microarray Offers Wider Range with Greater Sensitivity

By LabMedica International staff writers
Posted on 15 Mar 2011
Projects aimed at the development of procedures for personalized medicine as well as other biotechnology research will be able to take advantage of a new generation of microRNA (miRNA) microarrays.

The new "GeneChip miRNA 2.0 Array” is produced by Affymetrix, Inc. More...
(Santa Clara, CA, USA). It is an enhanced version of Affymetrix's highly regarded miRNA view system.

The GeneChip miRNA 2.0 Array offers the broadest coverage of known miRNA, encompassing 131 organisms on a single array, and nearly doubles the content of the previous array. Moreover, it is the only array that contains unique probe sequences designed to independently interrogate human, mouse, and rat precursor RNA (pre-miRNA) and mature miRNA in the same experiment.

The GeneChip miRNA 2.0 Array has excellent sensitivity across every miRNA transcript. Testing has demonstrated that the array could reproducibly detect 94% of all transcripts present in a 1.0 amol [10-18 mol] sample. Coupled with the Genisphere FlashTag Biotin RNA Labeling Kit, the new array maintains the same assay protocol, requiring only a 45-minute assay with no amplification or purification steps, and as little as 100 ng of input total RNA.

"This new GeneChip miRNA 2.0 Array demonstrates Affymetrix' commitment to stay at the forefront of gene expression analysis and to provide life scientists with relevant and timely content that is critical to research in gene expression and cellular function,” said Dr. Kevin Cannon, vice president of expression applications at Affymetrix. "With its complete and comprehensive view of all coding and noncoding miRNA, researchers gain greater access to the entire miRNA spectrum--from human to model organisms, at a competitive price.”


Related Links:
Affymetrix, Inc.



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.